Shanghai Haoyuan Chemexpress Co (SHSE:688131) Research & Development: ¥248 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688131 Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
92 GF Score
Price ¥70.55
GF Value ¥65.89
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai Haoyuan Chemexpress Co Research & Development?

Shanghai Haoyuan Chemexpress Co SHSE:688131 -0.63% 92 Research & Development is ¥248 Mil as of Mar. 2026. GuruFocus rates SHSE:688131 with a GF Score™ of 92/100 and a GF Value™ of ¥65.89 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai Haoyuan Chemexpress Co's Research & Development for the three months ended in Mar. 2026 was ¥65 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥248 Mil.

Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanghai Haoyuan Chemexpress Co Research & Development Related Terms

Shanghai Haoyuan Chemexpress Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shanghai Haoyuan Chemexpress Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haoyuan Chemexpress Co Research & Development Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.45 201.58 224.12 226.93 237.62

Shanghai Haoyuan Chemexpress Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.71 63.19 60.38 60.34 64.51
SHSE:688131
92GF Score
Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haoyuan Chemexpress Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥248 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥248 Mil mean?
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a Research & Development of ¥248 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors.
Is Shanghai Haoyuan Chemexpress Co's Research & Development too high?
Shanghai Haoyuan Chemexpress Co's current Research & Development is ¥248 Mil. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's Research & Development compare to ZTS and UTHR?
Shanghai Haoyuan Chemexpress Co's Research & Development of ¥248 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. Shanghai Haoyuan Chemexpress Co's current Research & Development is ¥248 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Fairly Valued. The stock's GF Value™ is ¥65.89, compared to a current price of ¥70.55 — trading 7.1% above its estimated fair value. The current Research & Development is ¥248 Mil. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current Research & Development is ¥248 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued. The current stock price of ¥70.55 is trading 7.1% above its estimated GF Value™ of ¥65.89. GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Fairly Valued.

Key valuation signals for SHSE:688131:

  • Research & Development: ¥248 Mil
  • GF Value™: ¥65.89 vs. price of ¥70.55 (7.1% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Haoyuan Chemexpress Co Business Description

Address No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
92GF Score

Get the complete analysis for SHSE:688131

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥70.55
Price
¥65.89
GF Value